There was no device malfunction.The device was received for evaluation and successfully passed testing, confirming proper functionality of the device and sensors.Available log files were retrieved and analyzed which showed the device was performing as designed and intended.Per log file review automated rinseback was not performed.A review of the device history record confirmed the product was released meeting all product design specifications and quality criteria.The system one user guide includes instructions for automated rinseback and warns to not attempt manual rinseback if the blood circuit is clotted or hemolyzed, or if you see air within the blood circuit or in the patient blood lines, or if otherwise directed by the center.(b)(4).
|
A report was received on 04 aug 2021 from the home therapy nurse (htn) of an (b)(6) male with an extensive medical history including hypotension and end stage renal disease, who stated the patient expired after completing rinseback following a home hemodialysis treatment on (b)(6) 2021.Additional information was received on 05 aug 2021 from the htn who stated, the patient elected to terminate treatment after unsuccessfully troubleshooting air alarms approximately nineteen minutes into therapy.Per the htn, the patient was lightheaded after rinseback, and became unresponsive.Emergency medical services (ems) were called, determined that the patient was in cardiac arrest and transported the patient to hospital.The patient subsequently expired later that day, time unspecified.The htn stated that the patient was "off the machine" when the event occurred, and the death was unrelated to nxstage product and therapy.
|